William L Stanford
Ottawa University
H-index: 55
North America-United States
Top articles of William L Stanford
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Progeria‐based vascular model identifies networks associated with cardiovascular aging and disease | Aging Cell | Mzwanele Ngubo Zhaoyi Chen Darin McDonald Rana Karimpour Amit Shrestha | 2024/4/4 |
Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy | Maxime WC Rousseaux Jean-Louis Parmasad Konrad Ricke Morgan Stykel Brodie Buchner-Duby | 2023/8/17 | |
Loss of VHL-mediated pRb regulation promotes clear cell renal cell carcinoma | bioRxiv | Ryan Russell Mercy Akuma Minjun Kim Chenxuan Zhu Ella Wiljer | 2024 |
Tissue‐Engineered Disease Modeling of Lymphangioleiomyomatosis Exposes a Therapeutic Vulnerability to HDAC Inhibition | Advanced Science | Adam Pietrobon Julien Yockell‐Lelièvre Nicole Melong Laura J Smith Sean P Delaney | 2023/9 |
Differential and lasting gene expression changes in circulating CD8 T cells in chronic HCV infection with cirrhosis and related insights on the role of Hedgehog signaling | bioRxiv | Jiafeng Li Agatha Vranjkovic Daniel Read Sean P Delaney William L Stanford | 2023 |
Tuberous Sclerosis Complex Kidney Lesion Pathogenesis: A Developmental Perspective | Adam Pietrobon William L Stanford | 2023/7/1 | |
Young Bone Marrow Sca-1 Cells Rejuvenate the Aged Heart by Promoting Epithelial-to-Mesenchymal Transition: Erratum | Theranostics | Jiao Li Shu-Hong Li Jun Wu Richard D Weisel Alina Yao | 2023 |
Differentiation and single-cell RNA-seq analyses of human pluripotent-stem-cell-derived renal organoids | STAR protocols | Eric Lian Adam Pietrobon William L Stanford | 2023/6/16 |
The mTOR Strikes Back: Vaping Liquid Induced mTOR Hyperactivation in Lymphangioleiomyomatosis (LAM) Exacerbates Endothelial Cell Apoptosis and Impairment of Network Formation … | M Ho M Ho WL Stanford C Librach | 2023/5 | |
Tissue-Specific Tumour Suppressor and Oncogenic Activities of the Polycomb-like Protein MTF2 | Mzwanele Ngubo Fereshteh Moradi Caryn Y Ito William L Stanford | 2023/9/27 | |
Rise of the Resistance: Cannabis Is Cytoprotective of Lymphangioleiomyomatosis (LAM) Cells but Fuels Lung Epithelium Dysregulation to Drive Stress-induced Premature Senescence | M Ho M Ho WL Stanford CL Librach | 2023/5 | |
Renal organoid modeling of tuberous sclerosis complex reveals lesion features arise from diverse developmental processes | Cell Reports | Adam Pietrobon Julien Yockell-Lelievre Trevor A Flood William L Stanford | 2022/7/5 |
Treatment of acute myeloid leukemia | 2022/5/24 | ||
Hydrogel biomimetic for invasive diseases | 2022/3/31 | ||
PINK1 Is a Negative Regulator of Growth and the Warburg Effect in Glioblastoma (vol 82, pg 4695, year 2022) | Cancer research | Sameer Agnihotri Brian Golbourn Xi Huang Marc Remke Susan Younger | 2016/8/15 |
Identification of a SARS-CoV-2 host metalloproteinase-dependent entry pathway differentially used by SARS-CoV-2 and variants of concern Alpha, Delta, and Omicron | bioRxiv | Mehdi Benlarbi Geneviève Laroche Corby Fink Kathy Fu Rory P Mulloy | 2022/2/22 |
Correction: PINK1 Is a Negative Regulator of Growth and the Warburg Effect in Glioblastoma | Cancer Research | Sameer Agnihotri Brian Golbourn Xi Huang Marc Remke Susan Younger | 2022/12/16 |
Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and Omicron | IScience | Mehdi Benlarbi Geneviève Laroche Corby Fink Kathy Fu Rory P Mulloy | 2022/11/18 |
Loss of TSC1 or TSC2 drives lineage infidelity and hamartoma formation in a renal organoid model of angiomyolipoma | Cancer Research | Adam Pietrobon Sean P Delaney Carole Doré Julien Yockell-Lelievre Lisa Julian | 2021/7/1 |
Three-dimensional drug screen identifies HDAC inhibitors as therapeutic agents in mTORC1-driven lymphangioleiomyomatosis | bioRxiv | Adam Pietrobon Julien Yockell-Lelièvre Nicole Melong Laura J Smith Sean P Delaney | 2021/7/4 |
